Is SPNV or MRK a better dividend investment in 2026?

SPNV currently yields 22.73% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: SPNV offers higher current income.

What is the dividend yield difference between SPNV and MRK?

SPNV has a forward dividend yield of 22.73% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 19.48 percentage points.

Home › Compare › SPNV vs MRK

SPNV vs MRK: Dividend Comparison 2026

SPNV yields 22.73% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SPNV wins by $55.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SPNV

● Live price

22.73%

Share price

$8.80

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$86.2K

Annual income

$8,927.11

Full SPNV calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — SPNV vs MRK

📍 SPNV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SPNV	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SPNV + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SPNV pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPNV

Annual income on $10K today (after 15% tax)

$1,931.82/yr

After 10yr DRIP, annual income (after tax)

$7,588.04/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, SPNV beats the other by $6,780.30/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPNV + MRK for your $10,000?

SPNV: 50%MRK: 50%

100% MRK50/50100% SPNV

Portfolio after 10yr

$58.5K

Annual income

$4,938.70/yr

Blended yield

8.45%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SPNV

No analyst data

Altman Z

9.9

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPNV buys

MRK buys

No recent congressional trades found for SPNV or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSPNVMRK

Forward yield	22.73% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$86.2K ✓	$30.7K
Annual income after 10y	$8,927.11 ✓	$950.29
Total dividends collected	$52.2K ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SPNV vs MRK ($10,000, DRIP)

Year	SPNV Portfolio	SPNV Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$12,973	$2,272.73	$11,192	$351.54	+$1.8K → SPNV
2	$16,636	$2,755.46	$12,524	$392.70	+$4.1K → SPNV
3	$21,103	$3,302.45	$14,015	$438.65	+$7.1K → SPNV
4	$26,496	$3,915.13	$15,682	$489.96	+$10.8K → SPNV
5	$32,944	$4,593.95	$17,547	$547.23	+$15.4K → SPNV
6	$40,589	$5,338.37	$19,632	$611.16	+$21.0K → SPNV
7	$49,577	$6,146.82	$21,963	$682.53	+$27.6K → SPNV
8	$60,064	$7,016.80	$24,571	$762.18	+$35.5K → SPNV
9	$72,213	$7,944.95	$27,486	$851.08	+$44.7K → SPNV
10	$86,195	$8,927.11	$30,745	$950.29	+$55.5K → SPNV

SPNV vs MRK: Complete Analysis 2026

SPNV — Stock

Supernova Partners Acquisition Company, Inc. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in Washington, D.C., District of Columbia.

Full SPNV Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this SPNV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPNV vs SCHD SPNV vs JEPI SPNV vs O SPNV vs KO SPNV vs MAIN SPNV vs JNJ SPNV vs ABBV SPNV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.